AUPH
NasdaqGMAurinia Pharmaceuticals Inc.
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 22 recent filings. 11 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Johnson Craig A Director | Grant / award | 23.93K | $0.00 | — | 2026-06-04 |
Goetz Kathleen Director | Grant / award | 23.93K | $0.00 | — | 2026-06-04 |
Nova Tina Susan Director | Grant / award | 23.93K | $0.00 | — | 2026-06-04 |
Bailey Jeffrey Allen Director | Grant / award | 23.93K | $0.00 | — | 2026-06-04 |
TANG KEVIN Director, Chief Executive Officer, 10% Owner | Buy (open market) | 2.3K | $15.35 | $35,289.65 | 2026-05-29 |
TANG KEVIN Director, Chief Executive Officer, 10% Owner | Buy (open market) | 262.68K | $15.31 | $4,021,661.42 | 2026-05-29 |
TANG KEVIN Director, Chief Executive Officer, 10% Owner | Buy (open market) | 343.52K | $15.28 | $5,249,000.88 | 2026-06-01 |
TANG KEVIN Director, Chief Executive Officer, 10% Owner | Buy (open market) | 99 | $15.34 | $1,518.66 | 2026-06-01 |
TANG KEVIN Director, Chief Executive Officer, 10% Owner | Buy (open market) | 206.01K | $15.28 | $3,147,756.40 | 2026-06-02 |
TANG KEVIN Director, Chief Executive Officer, 10% Owner | Code J | 10K | $1.65 | $16,500.00 | 2026-06-02 |
Robertson Stephen P. Chief Legal Officer | Grant / award | 115.54K | $0.00 | — | 2026-05-18 |
Hearne Michael S Chief Financial Officer | Grant / award | 116.14K | $0.00 | — | 2026-05-18 |
Hearne Michael S Chief Financial Officer | Grant / award | 70.23K | $0.00 | — | 2026-05-18 |
Cole Ryan Chief Operating Officer | Grant / award | 116.14K | $0.00 | — | 2026-05-18 |
Cole Ryan Chief Operating Officer | Grant / award | 70.23K | $0.00 | — | 2026-05-18 |
Keenan Greg SVP, Chief Medical Officer | Tax withholding | 8.07K | $14.32 | $115,548.08 | 2026-03-06 |
TANG KEVIN Director | Buy (open market) | 300K | $13.90 | $4,170,000.00 | 2026-02-27 |
TANG KEVIN Director | Buy (open market) | 214.84K | $14.12 | $3,033,526.68 | 2026-02-27 |
TANG KEVIN Director | Buy (open market) | 1.6K | $14.38 | $23,008.00 | 2026-02-27 |
TANG KEVIN Director | Buy (open market) | 83.56K | $14.33 | $1,197,429.13 | 2026-03-02 |
TANG KEVIN Director | Buy (open market) | 115.79K | $14.21 | $1,645,404.32 | 2026-03-02 |
TANG KEVIN Director | Buy (open market) | 184.21K | $14.22 | $2,619,437.76 | 2026-03-03 |
Source: SEC EDGAR Forms 4/4A (CIK 1600620). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
$AUPH any changes? https://finance.yahoo.com/quote/AUPH/analysis/?guccounter=1
$AUPH
$AUPH I would take any cowbell!
$AUPH Beer is cold, Sun is hot, Cigars are smooth, and girls are willing! Life is good...
$AUPH
$AUPH
$AUPH Markets should be green on possible deal with Iran. Should last couple days... 😁 😂 😀 🤣
$AUPH
$AUPH bullish piercing line... Needs to close above 15.18 for a bullish reversal... Chances are looking good considering Friday's price action! Need a little cowbell and we got!!! Come on Tang! Get it!!!
$AUPH 2nd Qrt Filings historically. As you can see they typically file in August.
$AUPH Pig was feeding off the company and the shareholders without any of his own money. Hopefully Tang doesn’t try using the company for his own benefit and not the benefit of the shareholders like taking it private at a reduced price. The fact that he doesn’t communicate is a red flag. Let’s hope that changes soon. It would be nice if they could announce an earnings release date rather than have us swinging in the wind.
$AUPH earnings are coming and if this gets back to 17, folks that thought about getting out previously when this ticker went there and didn’t will go this time unless something tempting is released. To say Tang is no better than 🐽 isn’t correct to me. The move he made to get rid of him proves that. Had to take out the trash and it hasn’t been that long compared to the torture pig gave us. Tang has been accumulating, giving investors some hope here. Bringing the stock price back to have your head above water at least. Communication may not be great but no Easter egg flubs like we had with 🐖 that drive price down which seemed to having that specific purpose. Been here a while, would like to see this end soon and I would not be surprised if it does. One thing is for sure, if 🐷 was still here that wouldn’t be on the table. Let’s go!! Have a great weekend everyone!
Latest news
Karyopharm Therapeutics (KPTI) Soars 5.3%: Is Further Upside Left in the Stock?
Sector Update: Healthcare Stocks Fall Monday Afternoon
Aurinia Pharmaceuticals Initiates Phase 4 PRESERVE Study in Lupus Nephritis Combination Therapy
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
Aurinia Pharmaceuticals and Four More Stocks See Activist Action
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.